-
1
-
-
0013118587
-
Platelet signal transduction
-
5th ed.; Coleman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, Eds. (J. B. Lippincott, Philadelphia)
-
Abrams CS, Brass LF (2006) Platelet signal transduction. In Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 5th ed.; Coleman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, Eds. (J. B. Lippincott, Philadelphia) pp 617-629.
-
(2006)
Hemostasis and Thrombosis: Basic Principles and Clinical Practice
, pp. 617-629
-
-
Abrams, C.S.1
Brass, L.F.2
-
2
-
-
33645861080
-
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
-
CHARISMA Investigators
-
Bhatt DL, et al.; CHARISMA Investigators (2006) Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354:1706-1717.
-
(2006)
N Engl J Med
, vol.354
, pp. 1706-1717
-
-
Bhatt, D.L.1
-
3
-
-
85058720552
-
The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: Study design and rationale
-
TRA*CER Executive and Steering Committees
-
TRA*CER Executive and Steering Committees (2009) The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: Study design and rationale. Am Heart J 158:327-334.e4.
-
(2009)
Am Heart J
, vol.158
-
-
-
4
-
-
68949156886
-
Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial
-
Morrow DA, et al. (2009) Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial. Am Heart J 158:335-341.e3.
-
(2009)
Am Heart J
, vol.158
-
-
Morrow, D.A.1
-
5
-
-
0014191175
-
Actions of thrombin and other coagulant and proteolytic enzymes on blood platelets
-
Davey MG, Lüscher EF (1967) Actions of thrombin and other coagulant and proteolytic enzymes on blood platelets. Nature 216:857-858.
-
(1967)
Nature
, vol.216
, pp. 857-858
-
-
Davey, M.G.1
Lüscher, E.F.2
-
6
-
-
0026035523
-
Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
-
Vu TK, Hung DT, Wheaton VI, Coughlin SR (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068.
-
(1991)
Cell
, vol.64
, pp. 1057-1068
-
-
Vu, T.K.1
Hung, D.T.2
Wheaton, V.I.3
Coughlin, S.R.4
-
7
-
-
0033559805
-
Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin
-
Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR (1999) Proteaseactivated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 103:879-887. (Pubitemid 29152634)
-
(1999)
Journal of Clinical Investigation
, vol.103
, Issue.6
, pp. 879-887
-
-
Kahn, M.L.1
Nakanishi-Matsui, M.2
Shapiro, M.J.3
Ishihara, H.4
Coughlin, S.R.5
-
8
-
-
0042703242
-
Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis
-
Conley PB, Delaney SM (2003) Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis. Curr Opin Hematol 10:333-338.
-
(2003)
Curr Opin Hematol
, vol.10
, pp. 333-338
-
-
Conley, P.B.1
Delaney, S.M.2
-
9
-
-
0035843178
-
Identification of the platelet ADP receptor targeted by antithrombotic drugs
-
DOI 10.1038/35051599
-
Hollopeter G, et al. (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409:202-207. (Pubitemid 32144286)
-
(2001)
Nature
, vol.409
, Issue.6817
, pp. 202-207
-
-
Hollopeter, G.1
Jantzen, H.-M.2
Vincent, D.3
Li, G.4
England, L.5
Ramakrishnan, V.6
Yang, R.-B.7
Nurden, P.8
Nurden, A.9
Julius, D.10
Conley, P.B.11
-
10
-
-
36148983750
-
Prasugrel versus clopidogrel in patients with acute coronary syndromes
-
TRITON-TIMI 38 Investigators
-
Wiviott SD, et al.; TRITON-TIMI 38 Investigators (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001-2015.
-
(2007)
N Engl J Med
, vol.357
, pp. 2001-2015
-
-
Wiviott, S.D.1
-
11
-
-
0022180156
-
Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation
-
Shattil SJ, Hoxie JA, Cunningham M, Brass LF (1985) Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem 260:11107-11114.
-
(1985)
J Biol Chem
, vol.260
, pp. 11107-11114
-
-
Shattil, S.J.1
Hoxie, J.A.2
Cunningham, M.3
Brass, L.F.4
-
12
-
-
0024357563
-
PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes
-
Larsen E, et al. (1989) PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 59:305-312.
-
(1989)
Cell
, vol.59
, pp. 305-312
-
-
Larsen, E.1
-
13
-
-
0032514474
-
A dual thrombin receptor system for platelet activation
-
DOI 10.1038/29325
-
Kahn ML, et al. (1998) A dual thrombin receptor system for platelet activation. Nature 394:690-694. (Pubitemid 28389797)
-
(1998)
Nature
, vol.394
, Issue.6694
, pp. 690-694
-
-
Kahn, M.L.1
Zheng, Y.-W.2
Huang, W.3
Bigornia, V.4
Zeng, D.5
Moff, S.6
Farese Jr., R.V.7
Tam, C.8
Coughlin, S.R.9
-
14
-
-
0034611727
-
PAR3 is a cofactor for PAR4 activation by thrombin
-
Nakanishi-Matsui M, et al. (2000) PAR3 is a cofactor for PAR4 activation by thrombin. Nature 404:609-613.
-
(2000)
Nature
, vol.404
, pp. 609-613
-
-
Nakanishi-Matsui, M.1
-
15
-
-
0035817822
-
Role of thrombin signalling in platelets in haemostasis and thrombosis
-
DOI 10.1038/35092573
-
Sambrano GR, Weiss EJ, Zheng YW, Huang W, Coughlin SR (2001) Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature 413:74-78. (Pubitemid 32843490)
-
(2001)
Nature
, vol.413
, Issue.6851
, pp. 74-78
-
-
Sambrano, G.R.1
Weiss, E.J.2
Zheng, Y.-W.3
Huang, W.4
Coughlin, S.R.5
-
16
-
-
44949114152
-
Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity
-
Chackalamannil S, et al. (2008) Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity. J Med Chem 51:3061-3064.
-
(2008)
J Med Chem
, vol.51
, pp. 3061-3064
-
-
Chackalamannil, S.1
-
17
-
-
0017672833
-
Interrelations of platelet aggregation and secretion
-
Charo IF, Feinman RD, Detwiler TC (1977) Interrelations of platelet aggregation and secretion. J Clin Invest 60:866-873.
-
(1977)
J Clin Invest
, vol.60
, pp. 866-873
-
-
Charo, I.F.1
Feinman, R.D.2
Detwiler, T.C.3
-
18
-
-
0034978187
-
Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs
-
Foster CJ, et al. (2001) Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 107:1591-1598.
-
(2001)
J Clin Invest
, vol.107
, pp. 1591-1598
-
-
Foster, C.J.1
-
19
-
-
60849138406
-
Functional variability of platelet response to clopidogrel correlates with P2Y(12) receptor occupancy
-
Bal Dit Sollier C, Berge N, Boval B, Hovsepian L, Drouet L (2009) Functional variability of platelet response to clopidogrel correlates with P2Y(12) receptor occupancy. Thromb Haemost 101:116-122.
-
(2009)
Thromb Haemost
, vol.101
, pp. 116-122
-
-
Bal Dit Sollier, C.1
Berge, N.2
Boval, B.3
Hovsepian, L.4
Drouet, L.5
-
20
-
-
74649085430
-
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): A randomised double-blind study
-
PLATelet inhibition and patient Outcomes investigators
-
Cannon CP, et al.; PLATelet inhibition and patient Outcomes investigators (2010) Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): A randomised double-blind study. Lancet 375:283-293.
-
(2010)
Lancet
, vol.375
, pp. 283-293
-
-
Cannon, C.P.1
-
21
-
-
70149101223
-
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
-
PLATO Investigators
-
Wallentin L, et al.; PLATO Investigators (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045-1057.
-
(2009)
N Engl J Med
, vol.361
, pp. 1045-1057
-
-
Wallentin, L.1
-
22
-
-
0345707537
-
Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis
-
André P, et al. (2003) Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis. Circulation 108:2697-2703.
-
(2003)
Circulation
, vol.108
, pp. 2697-2703
-
-
André, P.1
-
23
-
-
0032842812
-
Mechanisms of progression in native coronary artery disease: Role of healed plaque disruption
-
Mann J, Davies MJ (1999) Mechanisms of progression in native coronary artery disease: Role of healed plaque disruption. Heart 82:265-268.
-
(1999)
Heart
, vol.82
, pp. 265-268
-
-
Mann, J.1
Davies, M.J.2
-
24
-
-
0035916310
-
Healed plaque ruptures and sudden coronary death: Evidence that subclinical rupture has a role in plaque progression
-
Burke AP, et al. (2001) Healed plaque ruptures and sudden coronary death: Evidence that subclinical rupture has a role in plaque progression. Circulation 103:934-940.
-
(2001)
Circulation
, vol.103
, pp. 934-940
-
-
Burke, A.P.1
-
25
-
-
85047694005
-
12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries
-
DOI 10.1172/JCI200317864
-
Andre P, et al. (2003) P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest 112:398-406. (Pubitemid 38063768)
-
(2003)
Journal of Clinical Investigation
, vol.112
, Issue.3
, pp. 398-406
-
-
Andre, P.1
Delaney, S.M.2
LaRocca, T.3
Vincent, D.4
DeGuzman, F.5
Jurek, M.6
Koller, B.7
Phillips, D.R.8
Conley, P.B.9
-
26
-
-
9644291604
-
An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research
-
DOI 10.1016/j.thromres.2004.07.009, PII S0049384804004104
-
Wang X, Xu L (2005) An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research. Thromb Res 115:95-100. (Pubitemid 39572761)
-
(2005)
Thrombosis Research
, vol.115
, Issue.1-2
, pp. 95-100
-
-
Wang, X.1
Xu, L.2
|